Feasibility of asynchronous independent lung high-frequency oscillatory ventilation in the management of acute hypoxemic respiratory failure: A case report
Al. Graciano et al., Feasibility of asynchronous independent lung high-frequency oscillatory ventilation in the management of acute hypoxemic respiratory failure: A case report, CRIT CARE M, 28(8), 2000, pp. 3075-3077
Objective: To report the first case of the use of asynchronous independent
lung high-frequency oscillatory ventilation (AIL-HFOV) in the management of
acute hypoxemic respiratory failure in a large pediatric patient with mark
edly asymmetric lung disease.
Design: Case study.
Setting: Tertiary pediatric intensive care unit in a pediatric teaching hos
pital.
Patient A 17-yr-old, 87-kg male patient with trisomy 21 and with respirator
y failure and progressive hypoxemia because of pneumonia.
Interventions: Intubation with a 37-Fr double-lumen endobronchial tube and
ventilation with two oscillatory ventilators for a total of 16 days.
Measurements and Main Results: Hemodynamic data were obtained using a pulmo
nary artery catheter. Adequate oxygenation and ventilation were readily ach
ieved after institution of AIL-HFOV. The FIO2/PaO2 ratio increased from 52
to 224, and the shunt fraction decreased from 40 to 9 after 30 mins of AIL-
HFOV. Ro, was rapidly reduced from 1.0 to 0.4 on the right lung and to 0.6
on the left lung. Mean arterial pressure was maintained, the cardiac index
increased from 3.5 to 5.4 L/min/m(2), the systemic vascular resistance inde
x decreased from 1513 to 1225 dyne sec/cm(5).m(2), and the pulmonary vascul
ar resistance index decreased from 723 to 428 dyne sec/cm(5).m(2) without t
he need for additional fluid boluses or increases in inotropic support. No
airleaks developed during the entire hospital stay.
Conclusions: AIL-HFOV improved oxygenation and hemodynamic performance in t
his large patient. This case demonstrates that it is feasible to use two hi
gh-frequency oscillatory ventilators to independently ventilate the lungs o
f a large patient with markedly asymmetric lung disease. We believe that AI
L-HFOV deserves future study and development for the treatment of large pat
ients with acute hypoxemic respiratory failure and asymmetric lung disease
when other choices are limited.